Israeli biotech and deep-tech company CollPlant, which is traded on Nasdaq, is reporting a business and defense breakthrough for its subsidiary LightSolver.
The company signed a multiyear framework agreement with the Defense Ministry’s Directorate of Defense Research & Development (DDR&D), under which it will develop and supply its unique laser processor (LPU - Laser Processing Unit) for advanced and complex computing applications.

The current agreement follows a successful proof of concept conducted by the parties and includes an initial order covering the first 12 months of the engagement.
A Growth Engine in a Multibillion-Dollar Market
The move gives LightSolver a strategic government defense customer and strengthens the company’s transition from proof-of-capability stages to funded, revenue-generating development programs.
Alongside the company’s existing collaboration with aerospace giant Boeing, the agreement with DDR&D marks the defense sector as one of the company’s most significant growth engines.

LightSolver’s potential target market in the global defense sector is estimated at up to $5 billion annually, with a compound annual growth rate (CAGR) of about 15%.
Addressing the Silicon Chip Bottleneck
LightSolver’s technology offers an alternative to computing architectures based on conventional silicon chips and GPUs, which currently face performance bottlenecks, unusually high energy consumption and high cooling costs in data centers.

The company’s LPU operates with a fully optical architecture (Closed-loop all-optical core), translating multidimensional mathematical problems into physical processes involving the interaction of laser beams, enabling significantly faster computation times alongside substantial energy savings.
A Local Technological Achievement With an International Outlook
DDR&D views the collaboration as an opportunity to advance high-performance computing technologies and strengthen Israel’s technological leadership globally, while LightSolver’s management emphasizes that the capabilities being developed under this framework are also relevant to the advanced computing needs of allied militaries, foremost among them the United States.

The agreement also formalizes intellectual property arrangements and technology usage rights and constitutes a central pillar of CollPlant’s expansion strategy beyond its traditional activity in regenerative medicine.











